Several factors predict itch-specific quality of life in patients with chronic itch.
There are multiple factors predicting itch-specific quality of life in patients with chronic itch, according to a video oral abstract presentation at the American Society for Dermatologic Surgery (ASDS) Annual Meeting.1
“Itch is a common dermatological symptom, and it can severely affect the quality of life of patients,” said Siri Choragudi, a research fellow at the University of Miami Miller School of Medicine in Florida.
Study investigators sought to evaluate the sociodemographic and itch-specific factors that predict the itch-specific quality of life in patients with chronic itch. In the cross-sectional study, investigators recruited a cohort of male and female patients 18 years or older who attended an itch clinic in Miami from 2016 to 2022 with reports of itching for at least 6 weeks.
Investigators used an interviewer-administered questionnaire to report sociodemographic and itch-related factors, which included the following:
Responses were recorded using an itch-specific quality of life questionnaire, ItchyQoL, then each response was graded using a 5-point Likert rating scale.
The study included 534 patients, with a mean age of 58 years; 59% were women and 62% were non-Hispanic White. Results of the study demonstrated a mean intensity of itch of 8, 45% of patients had itch all day and night, and 40% had pain in the area of itch. Additionally, dry skin was the most common worsening factor (52%). Itch was most frequent in the upper limb (80%), trunk (73%), and lower limb (68%). The mean total itch-specific quality of life was 72 (range, 21-105).
The investigators noted that being non-Hispanic White predicted good quality of life compared with other ethnicities.“ In summary, sociodemographic factors such as female sex; body site location such as groin, buttocks, and upper limb; and worsening factors such as pain and heat in the itch area had the highest predictive value of poor quality of life in [patients with] chronic itch,” Choragudisaid.
Reference
1. Yosipovitch G, Choragudi S. Factors predicting the itch-specific quality of life among patients suffering from chronic itch. Presented at: American Society for Dermatologic Surgery Annual Meeting; October 6-10, 2022; Denver, CO.
Q&A: Pharmacist-Led Diabetes Management Transforms Patient Care and Clinical Outcomes
June 28th 2025An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.